BioScrip Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed against BioScrip, Inc. (“BioScrip” or “Company”) (NasdaqGS: BIOS) and several officers and directors for acts taken during the period of August 8, 2011 to September 20, 2013 (the “Class Period”).

Based upon the allegations in the class action, the firms are investigating additional legal claims against the officers and Board of Directors of BioScrip. If you are an affected BioScrip shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 239-4568, or via email at, or Zach Groover at Powers Taylor LLP, toll free (877) 728-9607, or via e-mail at There is no cost or fee to you.

In the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges that defendants’ misrepresented and/or failed to disclose that: a) BioScrip improperly distributed the product Exjade through its specialty pharmacy operations; b) a considerable portion of BioScrip’s revenues were gained through the violation of federal and state laws and regulations; and c) as a result of the above, BioScrip’s statements were materially false and misleading at all relevant times. According to the complaint, BioScrip’s stock price dropped dramatically after the true facts were revealed.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Powers Taylor LLP is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.

Copyright Business Wire 2010